HYPERION DEFI INC

Insightful analysis of Hyperion DeFi insider trades shows strong executive confidence and strategic positioning for future ophthalmic drug success.

Hyperion DeFi insider buys boost confidence as Phase II results show promising visual‑acuity gains for nAMD therapy, hinting at future FDA approval and market impact.